Duearity AB (DEAR) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Duearity AB (DEAR) has a cash flow conversion efficiency ratio of 0.036x as of June 2024. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-416.00K ≈ $-44.77K USD) by net assets (Skr-11.54 Million ≈ $-1.24 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see DEAR market cap overview for the company's overall valuation and market capitalisation.
Duearity AB - Cash Flow Conversion Efficiency Trend (2020–2023)
This chart illustrates how Duearity AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.
Duearity AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Duearity AB ranked by their cash flow conversion efficiency. See DEAR operating cash flow to total debt to evaluate how effectively operating cash flow covers total debt obligations.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Cardiff Property PLC
LSE:CDFF
|
-0.046x |
|
Renalytix AI plc
LSE:RENX
|
4.746x |
|
Hercules Site Services PLC
LSE:HERC
|
0.120x |
|
Quintegra Solutions Limited
NSE:QUINTEGRA
|
0.000x |
|
Challenger Energy Group PLC
LSE:CEG
|
-0.008x |
|
Global PVQ SE
HM:QCE
|
3.126x |
|
Subsea 7 SA
LSE:0OGK
|
-0.030x |
|
LogicMark Inc
NASDAQ:LGMK
|
-0.081x |
Annual Cash Flow Conversion Efficiency for Duearity AB (2020–2023)
The table below shows the annual cash flow conversion efficiency of Duearity AB from 2020 to 2023. View DEAR stock price and chart for real-time trading data and today's change.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2023-12-31 | Skr-2.39 Million ≈ $-256.77K |
Skr-24.36 Million ≈ $-2.62 Million |
10.207x | +404.16% |
| 2022-12-31 | Skr6.06 Million ≈ $652.48K |
Skr-20.35 Million ≈ $-2.19 Million |
-3.356x | -174.66% |
| 2021-12-31 | Skr11.04 Million ≈ $1.19 Million |
Skr-13.49 Million ≈ $-1.45 Million |
-1.222x | -331.51% |
| 2020-12-31 | Skr3.79 Million ≈ $408.19K |
Skr-1.07 Million ≈ $-115.58K |
-0.283x | -- |
About Duearity AB
Duearity AB (publ), a medical technology company, engages in the development and production of solutions for tinnitus. The company offers Tinearity G1, a medical device for people suffering from tinnitus that transmits white noise using bone conduction technology non-invasively to the inner ear in order to treat and relieve symptoms; and Tinearity-AI, which uses artificial intelligence to help pe… Read more